semaglutide and kidney infection Ozempic Approved for Diabetic Disease Semaglutide lowers UACR in overweight

Discover more.

Combining phentermine and Wegovy raises safety concerns that require medical oversight

Compare effectiveness, safety profiles, approved uses, pricing, and more

The Centers for Medicare & Medicaid Services (CMS) has announced the launch of the Medicare GLP-1 Bridge, a new initiative designed to expand access to certain GLP-1 medications for eligible Medicare beneficiaries enrolled in Medicare Part D prescription drug coverage

Built for research purposes only, not for human use

A weekly dose of semaglutide, the key ingredient in blockbuster medications Ozempic and Wegovy, helped seven out of 10 patients newly diagnosed with type 1 diabetes stop taking insulin after three to six months in a small study.